Sarah Spencer

Sarah Spencer has had an extensive career in corporate communications and public relations, holding key roles at various prominent companies in the biotechnology and healthcare industry. Currently, Sarah serves as the Vice President of Corporate Communications & Investor Relations at Vor Bio and is also the Founder & CEO of SJS Communications, a biotechnology communications consulting agency. Sarah's previous positions include Vice President of Corporate Communications at Astellas Gene Therapies, various leadership roles at GSK, Media Relations & Communications Specialist at Elan Pharmaceuticals, and Senior Account Supervisor at Berry & Company Public Relations. Sarah holds a Bachelor of Science degree in Communication from the University at Buffalo.